<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="39027">VLDL</z:chebi> chemical composition is related to plasma levels of <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated patients with primary <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> with or without <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> and subjects with normotriglyceridemia with <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The pattern observed in <z:hpo ids='HP_0000001'>all</z:hpo> the groups was an enrichment in the <z:chebi fb="0" ids="17855">triglyceride</z:chebi> content of <z:chebi fb="1" ids="39027">VLDL</z:chebi> and in apo B-<z:chebi fb="1" ids="39027">VLDL</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Compared to controls, LpC-III:B levels were higher in hypertriglyceridemic patients with low or <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> levels (7.3 +/- 0.6 vs. 14.9 +/- 1.8 and 12.3 +/- 2.8 mg/dl; P &lt; 0.005 and P &lt; 0.01, respectively) and LpE:B concentration was only increased in patients with <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> levels (3.1 +/- 0.5 vs. 6.3 +/- 1.0 mg/dl; P &lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>The activity of the cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> transfer protein was higher in hypertriglyceridemic patients with <z:hpo ids='HP_0003233'>low HDL-cholesterol</z:hpo> levels than in controls (380 +/- 25 vs. 262 +/- 14% cholesteryl <z:chebi fb="21" ids="35701">esters</z:chebi>/ml.h; P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>The most atypical <z:chebi fb="1" ids="39027">VLDL</z:chebi> particle was found in patients who combined an accumulation of <z:chebi fb="1" ids="39027">VLDL</z:chebi> particles and a reduction in <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> concentration </plain></SENT>
<SENT sid="6" pm="."><plain>These two parameters represent both ends of the cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi>-<z:chebi fb="0" ids="17855">triglyceride</z:chebi> transfer, a crucial factor for <z:chebi fb="1" ids="39027">VLDL</z:chebi> chemical composition and <z:chebi fb="17" ids="39025">HDL</z:chebi> levels </plain></SENT>
</text></document>